Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Corning to Develop Label-Free Screening Tech

NEW YORK (GenomeWeb News) – PerkinElmer and Corning will collaborate to develop label-free detection technologies for the drug discovery market, Corning said today.

Under the agreement, the companies will combine Corning's optical label-free detection technology with PerkinElmer's multi-label detection systems to offer next-generation drug discovery platforms.

The agreement will combine the Corning Epic system with PerkinElmer's technologies to "provide drug discovery and life science researchers with deeper insights into biomolecular and cellular interactions," PerkinElmer Bio-discovery President Richard Eglen said in a statement.

Financial and other terms of the pact were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.